Fwd: New Webinar: What Comes Next? Industry Takeaways from FDA’s Cell and Gene Therapy Listening Session

3 views
Skip to first unread message

Prash

unread,
Oct 9, 2025, 12:09:20 AM (11 days ago) Oct 9
to bioc...@googlegroups.com
 


Register Today for This Upcoming Free Webinar

Sponsored by:

Join Us for a Free Webinar

What Comes Next? Industry Takeaways from FDA’s Cell and Gene Therapy Listening Session

Friday, October 17, 2025

11:00 PDT, 14:00 EDT, 18:00 GMT

SPEAKERS

Paris Margaritis, PhD

Paris Margaritis, PhD

Chief Scientific Officer
GeneVentiv Therapeutics

Jacob Smith

Jacob Smith

Head of Technical Development & CMC Strategy
Viralgen

In this GEN webinar, an outstanding panel of CGT experts will unpack some of the key themes raised during the recent FDA Listening Session and examine their implications for the future of product development and regulatory strategy. They will discuss the role of prior knowledge across chemistry, manufacturing, and controls (CMC), nonclinical, clinical, and manufacturing contexts and its potential to inform efficiency, safety, and innovation. Webinar attendees will learn:

  • What types of data are most valuable to share and where the boundaries should be.
  • How sponsors and CDMOs can navigate data leveraging across partnerships and the product lifecycle.
  • Strategies for integrating knowledge across disciplines to strengthen development and risk assessment.

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.

Can't make it? Register anyway and we'll send you an on-demand link to watch at your convenience. 

Stay Connected:

 



--
Prashanth N Suravajhala, Ph.D.
Professor, Systems Genomics Group
Department of Biosciences, Room # 323D, AB-3 
Manipal University Jaipur, Dehmi Kalan 303007,  India.
Founder, Bioclues.org
Twitter: @prashbio

"One rule is important in science- only courageous people win "   ~ Max Planck
Reply all
Reply to author
Forward
0 new messages